NCT06082583
Not Yet Recruiting
Phase 2
A Randomized Controlled Trial of the Efficacy of Combining Traditional Tibetan and Remote Ischemic Conditioning on High Altitude Polycythemia
Capital Medical University0 sites300 target enrollmentNovember 1, 2023
ConditionsHigh Altitude Polycythemia
Overview
- Phase
- Phase 2
- Intervention
- Tibetan Medicine (Shiliu Jianwei Powder, Ershiwuwei Yuganzi Pills, Qiwei Tiexue Pill)
- Conditions
- High Altitude Polycythemia
- Sponsor
- Capital Medical University
- Enrollment
- 300
- Primary Endpoint
- The incidence of effective treatment
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
A multicenter, randomized controlled trial was designed to evaluate the effectiveness and safety of the comprehensive traditional Tibetan medicine program combined with remote ischemic conditioning on high altitude polycythemia.
Investigators
Ji Xunming,MD,PhD
Principal Investigator
Capital Medical University
Eligibility Criteria
Inclusion Criteria
- •Patients with high-altitude polycythemia aging 18 to 65 years.
Exclusion Criteria
- •Allergic to Tibetan medicine ingredients;
- •Inappropriate to receive Tibetan medicine treatment and/or remote ischemic conditioning.
Arms & Interventions
Tibetan Medicine Group
Intervention: Tibetan Medicine (Shiliu Jianwei Powder, Ershiwuwei Yuganzi Pills, Qiwei Tiexue Pill)
Tibetan Medicine-Remote Ischemic Conditioning Group
Intervention: Remote Ischemic Conditioning
Tibetan Medicine-Remote Ischemic Conditioning Group
Intervention: Tibetan Medicine (Shiliu Jianwei Powder, Ershiwuwei Yuganzi Pills, Qiwei Tiexue Pill)
Outcomes
Primary Outcomes
The incidence of effective treatment
Time Frame: Baseline and 1 month after treatment.
The hemoglobin levels decreased ≥20% after treatment compared to pre-treatment.
Similar Trials
Unknown
Phase 2
To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM)GBMNCT03746288CANbridge Life Sciences Ltd.60
Not Yet Recruiting
N/A
Clinical Study on the Noninvasive Lung Fluid Monitoring System in Guiding the Treatment of Heart FailureHeart FailureNCT06102031Shanghai Zhongshan Hospital1,000
Unknown
N/A
Evaluation of Efficacy and Safety of Votiva for Vaginal RejuvenationVaginal AtrophyVaginal RelaxationStress Urinary IncontinenceNCT03520426Walden, Jennifer L., M.D.,P.L.L.C.50
Recruiting
N/A
Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal ArteryPeripheral Artery DiseaseNCT05780359Shenzhen Salubris Pharmaceuticals Co., Ltd.280
Active, Not Recruiting
N/A
BioGlue as an Adjunct for Structural Repair and Hemostasis in Chinese Acute Type A Aortic Dissections PatientsType A Aortic DissectionNCT03369977CryoLife, Inc.202